サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1609687

日本のラテラルフローアッセイ市場レポート：技術、製品、用途、エンドユーザー、地域別、2024年～2032年

Japan Lateral Flow Assay Market Report by Technique, Product, Application, End User, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 116 Pages
納期
5～7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
日本のラテラルフローアッセイ市場レポート：技術、製品、用途、エンドユーザー、地域別、2024年～2032年
出版日: 2024年12月05日
発行: IMARC
ページ情報: 英文 116 Pages
納期: 5～7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本のラテラルフローアッセイ市場の市場規模は2023年に8億3,680万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに13億5,480万米ドルに達し、2024年から2032年の間に5.50%の成長率（CAGR）を示すと予測しています。感染症の流行の増加、ポイントオブケア検査（POCT）ソリューションの需要の高まり、ラテラルフローアッセイ技術の急速な進歩、規制当局の承認の高まり、健康への取り組みや啓発キャンペーンの高まりなどが、市場を後押しする要因の一部です。

本レポートで扱う主な質問

  • 日本のラテラルフローアッセイ市場はこれまでどのように推移し、今後どのように推移していくのか？
  • COVID-19が日本のラテラルフローアッセイ市場に与えた影響は？
  • 日本のラテラルフローアッセイ市場の技術別内訳は？
  • 日本のラテラルフローアッセイ市場の製品別内訳は？
  • 日本のラテラルフローアッセイ市場の用途別内訳は？
  • 日本のラテラルフローアッセイ市場のエンドユーザー別内訳は？
  • 日本のラテラルフローアッセイ市場のバリューチェーンにはどのような段階がありますか？
  • 日本のラテラルフローアッセイの主な促進要因と課題は？
  • 日本のラテラルフローアッセイ市場の構造と主要プレーヤーは？
  • 日本のラテラルフローアッセイ市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
  • 市場推定
  • 調査手法

第3章 エグゼクティブサマリー

第4章 日本のラテラルフローアッセイ市場：イントロダクション

  • 概要
  • 市場力学
  • 業界動向
  • 競合情報

第5章 日本のラテラルフローアッセイ市場情勢

  • 過去および現在の市場動向（2018～2023年）
  • 市場予測（2024～2032年）

第6章 日本のラテラルフローアッセイ市場：技術別の内訳

  • サンドイッチアッセイ
  • 競合アッセイ
  • マルチプレックス検出アッセイ

第7章 日本のラテラルフローアッセイ市場：製品別の内訳

  • キットと試薬
  • ラテラルフローリーダー

第8章 日本のラテラルフローアッセイ市場：用途別の内訳

  • 臨床試験
  • 獣医診断
  • 食品安全と環境試験
  • 医薬品開発と品質試験

第9章 日本のラテラルフローアッセイ市場：エンドユーザー別の内訳

  • 病院と診療所
  • 診断検査室
  • 在宅ケア
  • 製薬・バイオテクノロジー企業
  • その他

第10章 日本のラテラルフローアッセイ市場：競合情勢

  • 概要
  • 市場構造
  • 市場プレーヤーのポジショニング
  • 主要成功戦略
  • 競合ダッシュボード
  • 企業評価象限

第11章 主要企業のプロファイル

第12章 日本のラテラルフローアッセイ市場：業界分析

  • 促進要因・抑制要因・機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第13章 付録

目次
Product Code: SR112024A19351

Japan lateral flow assay market size reached US$ 836.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,354.8 Million by 2032, exhibiting a growth rate (CAGR) of 5.50% during 2024-2032. The increasing prevalence of infectious diseases, the growing demand for point-of-care testing (POCT) solutions, the rapid advancements in lateral flow assay technology, the rising regulatory approvals, and the escalating health initiatives and awareness campaigns are some of the factors propelling the market.

Lateral Flow Assay (LFA), a widely used diagnostic technique, operates by capillary action, allowing the rapid detection of specific analytes in biological samples. In this assay, a sample is applied to one end of a test strip containing immobilized capture reagents and signal-generating elements. As the sample migrates across the strip, it interacts with these components, forming visible test and control lines. LFA's active principle lies in its simplicity and quick results, making it ideal for point-of-care testing. The analyte's presence is indicated by a visible line, enabling users to assess results without the need for complex instrumentation. With applications ranging from infectious disease testing to pregnancy diagnostics, LFAs continue to gain prominence due to their user-friendly nature, rapid response times, and adaptability to diverse testing environments. As the demand for accessible and efficient diagnostic solutions persists, the active deployment of lateral flow assays contributes significantly to the evolution of rapid and point-of-care testing in various healthcare settings.

Japan Lateral Flow Assay Market Trends:

The market in Japan is majorly driven by the increasing emphasis on advanced healthcare solutions and diagnostics. LFAs, with their simplicity, speed, and effectiveness, align perfectly with the Japanese healthcare system's focus on providing timely and accessible diagnostics. As the country faces an aging population and an increase in chronic diseases, quick and efficient point-of-care testing becomes paramount, contributing significantly to the growing adoption of LFAs. Furthermore, the global impact of infectious diseases, highlighted by events like the COVID-19 pandemic, has underscored the importance of rapid and accurate diagnostic tools. LFAs, being instrumental in the detection of various infectious agents, including viruses and bacteria, are gaining traction in Japan's efforts to strengthen its diagnostic capabilities. The versatility of LFAs in detecting a range of analytes, from pathogens to biomarkers, positions them as valuable tools in managing public health challenges. Besides, the healthcare sector's inclination toward preventive care and early diagnosis further propels the market growth of LFAs. The adaptability of LFAs to various healthcare settings, including clinics, pharmacies, and remote locations, aligns well with Japan's commitment to expanding access to healthcare services across diverse demographics. Additionally, the collaboration between the Japanese government, research institutions, and healthcare providers in advancing diagnostic technologies creates a conducive environment for the adoption of LFAs. As the demand for rapid and reliable diagnostics continues to rise in Japan, driven by demographic shifts and evolving healthcare priorities, the market is poised for sustained growth, playing a vital role in enhancing the efficiency and accessibility of diagnostic testing throughout the country.

Japan Lateral Flow Assay Market Segmentation:

Technique Insights:

  • Sandwich Assays
  • Competitive Assays
  • Multiplex Detection Assays

Product Insights:

  • Kits and Reagents
  • Lateral Flow Readers
  • Digital/Mobile Readers
  • Benchtop Readers

Application Insights:

  • Clinical Testing
  • Infectious Disease Testing
  • Cardiac Marker Testing
  • Pregnancy and Fertility Testing
  • Cholesterol Testing/Lipid Profile
  • Drug Abuse Testing
  • Others
  • Veterinary Diagnostics
  • Food Safety and Environment Testing
  • Drug Development and Quality Testing

End User Insights:

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Home Care
  • Pharmaceutical and Biotechnology Companies
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan lateral flow assay market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan lateral flow assay market?
  • What is the breakup of the Japan lateral flow assay market on the basis of technique?
  • What is the breakup of the Japan lateral flow assay market on the basis of product?
  • What is the breakup of the Japan lateral flow assay market on the basis of application?
  • What is the breakup of the Japan lateral flow assay market on the basis of end user?
  • What are the various stages in the value chain of the Japan lateral flow assay market?
  • What are the key driving factors and challenges in the Japan lateral flow assay?
  • What is the structure of the Japan lateral flow assay market and who are the key players?
  • What is the degree of competition in the Japan lateral flow assay market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Lateral Flow Assay Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Lateral Flow Assay Market Landscape

  • 5.1 Historical and Current Market Trends (2018-2023)
  • 5.2 Market Forecast (2024-2032)

6 Japan Lateral Flow Assay Market - Breakup by Technique

  • 6.1 Sandwich Assays
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2018-2023)
    • 6.1.3 Market Forecast (2024-2032)
  • 6.2 Competitive Assays
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2018-2023)
    • 6.2.3 Market Forecast (2024-2032)
  • 6.3 Multiplex Detection Assays
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2018-2023)
    • 6.3.3 Market Forecast (2024-2032)

7 Japan Lateral Flow Assay Market - Breakup by Product

  • 7.1 Kits and Reagents
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2018-2023)
    • 7.1.3 Market Forecast (2024-2032)
  • 7.2 Lateral Flow Readers
    • 7.2.1 Overview
    • 7.2.3 Historical and Current Market Trends (2018-2023)
    • 7.2.3 Market Segmentation
      • 7.2.3.1 Digital/Mobile Readers
      • 7.2.3.2 Benchtop Readers
    • 7.2.4 Market Forecast (2024-2032)

8 Japan Lateral Flow Assay Market - Breakup by Application

  • 8.1 Clinical Testing
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2018-2023)
    • 8.1.3 Market Segmentation
      • 8.1.3.1 Infectious Disease Testing
      • 8.1.3.2 Cardiac Marker Testing
      • 8.1.3.3 Pregnancy and Fertility Testing
      • 8.1.3.4 Cholesterol Testing/Lipid Profile
      • 8.1.3.5 Drug Abuse Testing
      • 8.1.3.6 Others
    • 8.1.4 Market Forecast (2024-2032)
  • 8.2 Veterinary Diagnostics
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2018-2023)
    • 8.2.3 Market Forecast (2024-2032)
  • 8.3 Food Safety and Environment Testing
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2018-2023)
    • 8.3.3 Market Forecast (2024-2032)
  • 8.4 Drug Development and Quality Testing
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2018-2023)
    • 8.4.3 Market Forecast (2024-2032)

9 Japan Lateral Flow Assay Market - Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2018-2023)
    • 9.1.3 Market Forecast (2024-2032)
  • 9.2 Diagnostic Laboratories
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2018-2023)
    • 9.2.3 Market Forecast (2024-2032)
  • 9.3 Home Care
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2018-2023)
    • 9.3.3 Market Forecast (2024-2032)
  • 9.4 Pharmaceutical and Biotechnology Companies
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2018-2023)
    • 9.4.3 Market Forecast (2024-2032)
  • 9.5 Others
    • 9.5.1 Historical and Current Market Trends (2018-2023)
    • 9.5.2 Market Forecast (2024-2032)

10 Japan Lateral Flow Assay Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Product Portfolio
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Product Portfolio
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Product Portfolio
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Product Portfolio
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Product Portfolio
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

12 Japan Lateral Flow Assay Market - Industry Analysis

  • 12.1 Drivers, Restraints, and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix